Authors and Editors
Author: Gayle M. Galletta, MD,
FACEP, Clinical Associate Professor, Department of Emergency Medicine, University of Massachusetts.
Editor: Jerry R. Balentine, DO,
Previous contributing coauthor and editors:
Hasnain M. Khandwala, MD, FRCPC, Assistant Professor, Department of Medicine, Division of Endocrinology, University of Saskatchewan, Canada.
Editors: Arthur B. Chausmer, MD, PhD, FACP, FACE, FACN, CNS, Affiliate Research Professor, Bioinformatics and Computational Biology Program, School of Computational Sciences; Principal, C/A Informatics, LLC; Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine; George T Griffing, MD, Director, Division of General Internal Medicine, Professor, Department of Internal Medicine, St Louis University.
Allison, D.B., et al. "Controlled-release phentermine/topiramate in severely obese adults: a randomized controlled trial (EQUIP)." Obesity 20.2 Feb. 2012: 330-342.
Douketis, J.D., C. Macie, L. Thabane, and D.F. Williamson. "Systematic Review of Long-Term Weight Loss Studies in Obese Adults: Clinical Significance and Applicability to Clinical Practice."
Int J Obesity (2005): 1153-1167.
Ebbeling, C.B., and D.S. Ludwig. "Tracking Pediatric Obesity, an Index of Uncertainty?" JAMA (2008): 2442-2443.
Fidler, M.C., et al. "A one-year randomized trial of lorcaserin for weight loss in obese and overweight adults: the BLOSSOM trial." J Clin Endocrinol Metab 96.10 Oct. 2011: 3067-3077.
Flegal, K.M., M.D. Carroll, C.L. Ogden, and L.R. Curtin. "Prevalence and Trends in Obesity Among U.S. Adults, 1999-2008." JAMA 303.3 (2010): 235–241.
Gadde, K.M., et al. "Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomized, placebo-controlled, phase 3 trial."
Lancet 377.9774 Apr. 16, 2011: 1341-1352.
Kernan, W.N., C.M. Viscoli, L.M. Brass, et al. "Phenylpropanolamine and the Risk of Hemorrhagic Stroke." N Engl J Med 343 (2000): 1826.
Klein, S., et al. "Absence of an Effect of Liposuction on Insulin Action and Risk Factors for Coronary Heart Disease." N Engl J Med 250.25 (2004): 2549-2557.
Klein, S., et al. "Clinical Implications of Obesity With Specific Focus on Cardiovascular Disease: A Statement for Professionals From the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: Endorsed by the American College of Cardiology Foundation." Circulation 110.18 (2004): 2952-2967.
Li, Z., et al. "Meta-analysis: Pharmacologic Treatment on Obesity." Ann Intern Med 142.7 (2005): 532-546.
O'Brien, P.E., et al. "Treatment of Mild to Moderate Obesity With Laparoscopic Adjustable Gastric Banding or an Intensive Medical Program: A Randomized Trial." Ann Int Med 144.9 (2006): 625-633.
Ogden, C.L., M.D. Carroll, and K.M. Flegal. "High Body Mass Index for Age Among US Children and Adolescents, 2003-2006." JAMA 299.20 (2008): 2401-2405.
Padwal, R., S.K. Li, and D.C. Lau. "Long-term Pharmacotherapy for Obesity and Overweight." Cochrane Database Syst Rev (2004).
Poirier, P., et al. "Obesity and Cardiovascular Disease: Pathophysiology, Evaluation and Effect of Weight Loss: An Update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical activity, and Metabolism." Circulation 113.6 (2006): 898-918.
Sjostrom, L., et al. "Lifestyle, Diabetes, and Cardiovascular Risk Factors 10 Years After Bariatric Surgery." N Engl J Med (2004): 2683-2693.
Whitmer, R.A., et al. "Central Obesity and Increased Risk of Dementia More Than Three Decades Later." Neurology (2008).
Medically Reviewed by a Doctor on 8/23/2012
Gayle M. Galletta, MD, FACEP
Patient Comments & Reviews
The eMedicineHealth doctors ask about Obesity: